ARUN PAPAIAH
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
Biotech startups: Govt steps in where investors fear to treadA flagship government-funding programme has provided a springboard to India's biotechnology industry by backing innovative and risky projec...
Aten Porus Lifesciences: Firm is developing drugs to fight a host of rare diseases globallyTo begin with, the duo decided to focus on Niemann-Pick Type C (NPC) disorder that’s also referred to as Childhood Alzheimer’s.
- Load More